MCP
IBB icon

Militia Capital Partners’s iShares Biotechnology ETF IBB Stock Holding History

Militia Capital Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.82M Sell
10,800
-5,700
-35% -$926K 0.69% 37
2025
Q3 		$2.38M Buy
16,500
+1,500
+10% +$205K 1.1% 18
2025
Q2 		$1.9M Buy
+15,000
New +$1.84M 0.88% 26

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Militia Capital Partners's IBB Position: Q4 2025 in Review

Militia Capital Partners reduced its iShares Biotechnology ETF (IBB) stake by 35% in Q4 2025, selling an estimated $926K and leaving 10,800 shares worth $1.82M. The position accounts for 0.69% of the portfolio, ranked #37.

Militia Capital Partners first reported a position in IBB in Q2 2025 and has held it in 3 quarters since. The position peaked at $2.38M in Q3 2025. 956 funds tracked by Wall St. Rank hold IBB as of Q4 2025.

  • Militia Capital Partners held 10,800 shares of iShares Biotechnology ETF worth $1.82M as of Q4 2025.
  • Militia Capital Partners sold 5,700 iShares Biotechnology ETF shares in Q4 2025, an estimated $926K.
  • iShares Biotechnology ETF made up 0.69% of Militia Capital Partners's portfolio in Q4 2025, its #37 holding.
  • Militia Capital Partners first reported a position in iShares Biotechnology ETF in Q2 2025 and has held it in 3 quarters since.
  • Militia Capital Partners's iShares Biotechnology ETF position peaked at $2.38M in Q3 2025.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.

Based on Militia Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.